Aashish Kumar, Ravinder Verma, Kunwar Pal, Deepika Purohit, Parijat Pandey, Vineet Mittal, Deepak Kaushik
Aashish Kumar1, Ravinder Verma2, Kunwar Pal3, Deepika Purohit3, Parijat Pandey4, Vineet Mittal1, Deepak Kaushik1*
1Department of Pharmaceutical Sciences, Maharshi Dayanand University, Rohtak – 124001, Haryana, India.
2Department of Pharmacy, School of Medical and Allied Sciences (SoMAS), G. D. Goenka University,
Sohna Road, Gurugram – 122103.
3Department of Pharmaceutical Sciences, Indira Gandhi University, Meerpur, Rewari, Haryana - 123401, India.
4Department of Pharmaceutical Sciences, Gurugram University, Gurugram – 122018, India.
Volume - 15,
Issue - 7,
Year - 2022
Topical route of drug administration is more effective therapy for improving patient compliance and bioavailability. The topical administration of analgesics allows effective and painless deliverance of medicament with least side-effects. This investigation was aimed to develop and evaluate Diclofenac emulgel for topical drug delivery with enhanced anti-inflammatory and analgesic potential. Diclofenac is used as a first-line drug for acute and chronic pain and inflammation from a variety of causes. When applied topically the advantage of the drug is the avoidance of the first-pass metabolism, better patient compliance and site-specific for their action. Emulgel was prepared by using HPMC K4M as a gelling agent, light liquid paraffin as the oil base, Kollicream 3C and Kolliphor CS20 as emulsifiers via the QbD method. The emulgel formulation of diclofenac was optimized by central composite design and determines the effect of excipients on in vitro release. Emulgel formulation was evaluated for pH, drug content, viscosity, in vitro drug release and stability study. Optimized formulation showed pH, drug content and viscosity in an acceptable range. Based on the results of this investigation, it was summarized that diclofenac emulgel has a promising potential as an alternative to the conventional marketed dosage form.
Cite this article:
Aashish Kumar, Ravinder Verma, Kunwar Pal, Deepika Purohit, Parijat Pandey, Vineet Mittal, Deepak Kaushik. Quality by design approach for developing Emulgel of Diclofenac with central composite Design and Evaluation using in vitro release testing. Research Journal of Pharmacy and Technology. 2022; 15(7):3260-6. doi: 10.52711/0974-360X.2022.00547
Aashish Kumar, Ravinder Verma, Kunwar Pal, Deepika Purohit, Parijat Pandey, Vineet Mittal, Deepak Kaushik. Quality by design approach for developing Emulgel of Diclofenac with central composite Design and Evaluation using in vitro release testing. Research Journal of Pharmacy and Technology. 2022; 15(7):3260-6. doi: 10.52711/0974-360X.2022.00547 Available on: https://www.rjptonline.org/AbstractView.aspx?PID=2022-15-7-69
1. Haroutiunian S, Drennan DA, Lipman AG. Topical NSAID therapy for musculoskeletal pain. Pain Medicine. 2010; 11(4): 535-549.
2. Atzeni F, Masala IF, Sarzi-Puttini P. A review of chronic musculoskeletal pain: Central and peripheral effects of diclofenac. Pain and Therapy. 2018; 7(2): 163-177.
3. Hamed R, Basil M, AlBaraghthi T, Sunoqrot S, Tarawneh O. Nanoemulsion-based gel formulation of diclofenac diethylamine: design, optimization, rheological behavior and in vitro diffusion studies. Pharmaceutical Development and Technology. 2016; 21(8): 980-989.
4. Altman R, Bosch B, Brune K, Patrignani P, Young C. Advances in NSAID development: Evolution of diclofenac products using pharmaceutical technology. Drugs. 2015; 75(8): 859-877.
5. Khullar R, Kumar D, Seth N, Saini S. Formulation and evaluation of mefenamic acid emulgel for topical delivery. Saudi Pharmaceutical Journal. 2012; 20(1): 63-67.
6. Mohamed MI. Optimization of chlorphenesin emulgel formulation. AAPS Journal. 2004; 6(3): 81-87.
7. Hardenia A, Jayronia S, Jain S. Emulgel: An emergent tool in topical drug delivery. International Journal of Pharmaceutical Sciences and Research. 2014; 5(5): 1653.
8. Kaushik R, Budhwar V, Kaushik D. An overview on recent patents and technologies on solid dispersion. Recent Patents on Drug Delivery and Formulations. 2020;14(1):63-74. doi:10.2174/1872211314666200117094406.
9. Kumar D, Singh J, Antil M, Kumar V. Emulgel-novel topical drug delivery system-a comprehensive review. International Journal of Pharmaceutical Sciences and Research. 2016; 7(12): 4733.
10. Foldvari M. Non-invasive administration of drugs through the skin: Challenges in delivery system design. Pharmaceutical Science and Technology Today. 2000; 3(12): 417-425.
11. Pandey A, Mittal A, Chauhan N, Alam S. Role of surfactants as penetration enhancer in transdermal drug delivery system. Journal of Molecular Pharmaceutics and Organic Process Research. 2014; 2(113): 2-7.
12. Shahin M, Hady SA, Hammad M, Mortada N. Novel jojoba oil-based emulsion gel formulations for clotrimazole delivery. AAPS PharmSciTech. 2011; 12(1): 239-247.
13. Thakker KD, Chern WH. Development and validation of in vitro release tests for semisolid dosage forms-case study. Dissolution Technologies. 2003; 10(2): 10-16.
14. Miller MA, Kasting G. A measurement of the unstirred aqueous boundary layer in a Franz diffusion cell. Pharmaceutical Development and Technology. 2012; 17(6): 705-711.
15. Shah VP, Elkins JS, Williams RL. Evaluation of the test system used for in vitro release of drugs for topical dermatological drug products. Pharmaceutical Development and Technology. 1999; 4(3): 377-385.
16. Verma R, Mittal V, Kaushik D. Quality based design approach for improving oral bioavailability of valsartan loaded SMEDDS and study of impact of lipolysis on the drug diffusion. Drug Delivery Letters. 2018; 8(2): 130–139.
17. Yu LX, Amidon G, Khan MA, Hoag SW, Polli J, Raju GK, Woodcock J. Understanding pharmaceutical quality by design. AAPS Journal. 2014; 16(4): 771–783.
18. Gujral G, Kapoor D, Jaimini M. An updated review on design of experiment (DoE) in pharmaceuticals. Journal of Drug Delivery and Therapeutics. 2018; 8(3): 147-152.
19. Bolla PK, Clark BA, Juluri A, Cheruvu HS, Renukuntla. Journal Evaluation of formulation parameters on permeation of ibuprofen from topical formulations using Strat-M® membrane. Pharmaceutics, 2020; 12(2): 151.
20. ICH. Guidance for Industry: Q8 (R2) Pharmaceutical Development; U.S. Department of Health and Human Services: Washington, DC, USA. 2009; pp. 1–29.
21. De Oliveira Neto AS, Souza I, Amorim M, de Freitas Souza T, Rocha VN, do Couto RO, Fabri RL, de Freitas Araújo MG. Antifungal efficacy of atorvastatin-containing emulgel in the treatment of oral and vulvovaginal candidiasis. Med. Mycol. 2020; myaa071. Advance online publication. https://doi.org/10.1093/mmy/myaa071
22. Yassin GE. Formulation and evaluation of optimized clotrimazole emulgel formulations. Journal of Pharmaceutical Research International. 2014; 1014-1030.
23. Gul R, Ahmed N, Ullah N, Khan MI, Elaissari A, Rehman AU. Biodegradable ingredient-based emulgel loaded with Ketoprofen nanoparticles. AAPS PharmSciTech. 2018; 19(4): 1869–1881.
24. Burki IK, Khan MK, Khan BA, Uzair B, Braga VA, Jamil QA. Formulation development, characterization, and evaluation of a novel dexibuprofen-capsaicin skin emulgel with improved in vivo anti-inflammatory and analgesic effects. AAPS PharmSciTech. 2020; 21(6): 211.
25. Verma R, Kaushik A, Almeer R, Rahman MH, Abdel-Daim MM, Kaushik D. Improved pharmacodynamic potential of rosuvastatin by self-nanoemulsifying drug delivery system: An in vitro and in vivo evaluation. International Journal of Nanomedicine. 2021; 16:905-924. Published 2021 Feb 9. doi:10.2147/IJN.S287665
26. Kapoor D, Vyas RB, Lad C, Patel M, Lal B, Parmar R. Formulation, development and characterization of emulgel of an NSAID’S. Pharma Chem. Journal. 2014; 1: 9-16.
27. Rawooth M, Qureshi D, Hoque M, Prasad M, Mohanty B, Alam MA, Anis A, Sarkar P, Pal K. Synthesis and characterization of novel tamarind gum and rice bran oil-based emulgels for the ocular delivery of antibiotics. International Journal of Biological Macromolecules. 2020; S0141-8130(20): 33993-339113. Advance online publication. https://doi.org/10.1016/j.ijbiomac.2020.07.231
28. Shanmugarajan TS, Selvan NK, Uppuluri V. Development and characterization of squalene-loaded topical agar-based emulgel scaffold: Wound healing potential in full-thickness burn model. Int. Journal of Low. Extrem. Wounds. 2020, 1534734620921629. Advance online publication.
29. Verma R, Kaushik D. Design and optimization of candesartan loaded self-nanoemulsifying drug delivery system for improving its dissolution rate and pharmacodynamic potential. Drug Delivery. 2020; 1: 756-771.
30. Food and drug administration (FDA). Guidance for industry: SUPAC-SS nonsterile semisolid dosage forms, scale-up and post-approval changes, chemistry, manufacturing, and controls, in vitro release testing and in vivo bioequivalence documentation. Rockville: Centre of Drug Evaluation and Research, 1997; pp. 26.